You are here

Article Text

Article menu

Download PDFPDF

Miscellaneous
Treatment of latent tuberculosis with rifampicin is associated with higher completion rates
Free
  1. V Nadig
  1. Clinical Fellow, Papworth Hospital, Cambridge, UK; vidya.nadig@papworth.nhs.uk

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    ▴ Page KR, Sifakis F, Montes de Oca R, et al. Improved adherence and less toxicity with rifampicin vs. isoniazid for treatment of latent tuberculosis. Arch Intern Med2006;166:1863–70.
    OpenUrlCrossRefPubMedWeb of Science

    In this retrospective study, medical records of 2255 patients who received treatment for latent tuberculosis infection (LTBI) at a US centre between January 1999 and January 2004 were reviewed. Adherence to LTBI treatment was …

    View Full Text